Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03196310 · ClinicalTrials.gov registry record · NA
Single Blinded First CMC Osteoarthritis Treatment
A NA study of Osteoarthritis Thumb, sponsored by Kettering Health Network.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT03196310: Recruiting NA study of Osteoarthritis Thumb, sponsored by Kettering Health Network.
NCT03196310 is a NA study of Osteoarthritis Thumb that is actively recruiting participants, run by Kettering Health Network. The registered enrollment target is 150 participants, below the 429-participant average among 3 other Osteoarthritis Thumb trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03196310, a NA study of Osteoarthritis Thumb, is actively recruiting participants, sponsored by Kettering Health Network.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
Single blinded PRP vs. Corticosteroid vs. Placebo (normal saline) intra-articular injection for basal joint arthritis.
Primary Outcome
functional score
Conditions Studied
Interventions
- OTHER Normal Saline
- DRUG Platelet Concentrate
- DRUG Corticosteroid injection
Study Locations (1)
Ohio
- Orthopedic Associates of Southwest Ohio - Centerville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2018-09-01 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
What NCT03196310 shows while recruiting
NCT03196310 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 429-participant average among 3 other Osteoarthritis Thumb trials with a reported enrollment target (65% lower).
The record links to 1 condition, with Osteoarthritis Thumb appearing as the primary indexed condition, and to 3 interventions - of which Normal Saline is the first listed.
NCT03196310 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03196310 about?
NCT03196310 is a clinical study titled "Single Blinded First CMC Osteoarthritis Treatment". Single blinded PRP vs. Corticosteroid vs. Placebo (normal saline) intra-articular injection for basal joint arthritis.
What is the current status of trial NCT03196310?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2018-09-01. Estimated completion is 2025-03-31.
What conditions does trial NCT03196310 study?
This clinical trial studies the following conditions: Osteoarthritis Thumb.
What interventions are being tested in trial NCT03196310?
The interventions under investigation include: Normal Saline (OTHER), Platelet Concentrate (DRUG), Corticosteroid injection (DRUG).
Who is sponsoring clinical trial NCT03196310?
This trial is sponsored by Kettering Health Network, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03196310 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis Thumb
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI